Tamara W. Van Hal

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

What Is the Diagnostic Capacity of Existing Severity Scoring Tools for Nail Psoriasis?

What Is the Diagnostic Capacity of Existing Severity Scoring Tools for Nail Psoriasis?

Journal: International journal of dermatology

Published: May 28, 2025

Characteristics, risk factors, and disease course of musculoskeletal manifestations in patients with inflammatory bowel disease: a prospective longitudinal cohort study.

Characteristics, risk factors, and disease course of musculoskeletal manifestations in patients with inflammatory bowel disease: a prospective longitudinal cohort study.

Journal: European journal of gastroenterology & hepatology

Published: February 20, 2025

Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry.

Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry.

Journal: The Journal of dermatological treatment

Published: January 24, 2024

Development of a New Referral Tool to Identify Psoriasis Patients with Concomitant Psoriatic Arthritis: Results of the Prospective DAPPER Cohort.

Development of a New Referral Tool to Identify Psoriasis Patients with Concomitant Psoriatic Arthritis: Results of the Prospective DAPPER Cohort.

Journal: Acta dermato-venereologica

Published: November 02, 2022

Discovery of Psoriatic Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER) Study: A Prospective Observational Cohort.

Discovery of Psoriatic Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER) Study: A Prospective Observational Cohort.

Journal: Acta dermato-venereologica

Published: July 12, 2022

Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial.

Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial.

Journal: The Lancet. Rheumatology

Published: December 21, 2021

Determinants of work and social participation in patients with psoriatic arthritis in the Netherlands: an observational study.

Determinants of work and social participation in patients with psoriatic arthritis in the Netherlands: an observational study.

Journal: BMC rheumatology

Published: November 23, 2021

Corrigendum to: Measuring disease activity in psoriatic arthritis: PASDAS implementation in a tightly monitored cohort reveals residual disease burden.

Corrigendum to: Measuring disease activity in psoriatic arthritis: PASDAS implementation in a tightly monitored cohort reveals residual disease burden.

Journal: Rheumatology (Oxford, England)

Published: November 17, 2021

Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER): Protocol for a Longitudinal Observational Study.

Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER): Protocol for a Longitudinal Observational Study.

Journal: JMIR research protocols

Published: June 30, 2021

Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review.

Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review.

Journal: Arthritis research & therapy

Published: January 28, 2021

The Skin May Clear But the Arthritis Won't Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy.

The Skin May Clear But the Arthritis Won't Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy.

Journal: Psoriasis (Auckland, N.Z.)

Published: July 07, 2020

Measuring disease activity in psoriatic arthritis: PASDAS implementation in a tightly monitored cohort reveals residual disease burden.

Measuring disease activity in psoriatic arthritis: PASDAS implementation in a tightly monitored cohort reveals residual disease burden.

Journal: Rheumatology (Oxford, England)

Published: June 04, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026